6 results
10-Q
2024 Q1
MREO
Mereo Biopharma Group Plc
15 May 24
Quarterly report
4:19pm
March 31, | December 31, | |||||||
2024 | 2023 | |||||||
($'000) | ($'000) | |||||||
Accrued research and development costs | $ | 566 | $ | 1,821 | ||||
Accrued legal fees | 375 | 266 | ||||||
Accrued bonus | 428 | 1,624 | ||||||
Accrued audit fees | 417 | 671 | ||||||
Accrued professional fees | 353 | 338 | ||||||
Accrued local taxes | — | 382 | ||||||
Other accrued expenses | 400 | 365 | ||||||
Total | $ | 2,539 | $ | 5,467 |
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
The fees payable to directors for service on the board of directors and for service on each committee of the board of directors on which the director is a member are as follows:
Member Annual Fee (1) | Chairperson Annual Fee (1) | |||||||
($) | ($) | |||||||
Board of Directors | 39,463 | 40,991 | ||||||
Audit and Risk Committee | 7,638 | 19,732 | ||||||
Remuneration Committee | 5,601 | 11,712 | ||||||
Nomination and Corporate Governance Committee | 4,456 | 8,911 | ||||||
Research and Development Committee | 5,092 | 10,184 |
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
The table below sets forth a summary of the fees billed to the Company by our auditors for professional services rendered for the fiscal years ended December 31, 2023 and December 31, 2022. All such audit and audit-related services were pre-approved by the Audit and Risk Committee.
Fees | December 31, 2023 ($ ‘000) | December 31, 2022 ($ ‘000) | ||||||
Audit Fees(1) | 1,162 | 489 | ||||||
Audit-related Fees(2) | 213 | 104 | ||||||
Tax Fees | — | — | ||||||
All Other Fees(3) | 3 | — | ||||||
Total | 1,378 | 592 |
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
December 31, | ||||||||
2023 | 2022 | |||||||
($'000) | ($'000) | |||||||
Accrued research and development costs | $ | 1,821 | $ | 2,336 | ||||
Accrued legal fees | 266 | 132 | ||||||
Accrued bonus | 1,624 | 1,863 | ||||||
Accrued audit fees | 671 | 382 | ||||||
Accrued professional fees | 338 | 183 | ||||||
Accrued local taxes | 382 | — | ||||||
Other accrued expenses | 365 | 540 | ||||||
Total | $ | 5,467 | $ | 5,436 |
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
2023 | 2022 | |||||||
Types of Fees | ($'000) | ($'000) | ||||||
Audit fees (1) | 1,162 | 489 | ||||||
Audit-related fees (2) | 213 | 104 | ||||||
Tax fees | — | — | ||||||
All other fees (3) | 3 | — | ||||||
Total Fees | 1,378 | 592 |
10-K
f4e drl03d2ien
27 Mar 24
Annual report
5:20pm
- Prev
- 1
- Next